Chemed Dual-Core Business Portfolio of H Diagram

Strengths

• One business contributes about 65% of revenue and benefits from demographic structural rigid demand
• Roto-Rooter exhibits strong cash cow attributes with low capital expenditures
• Brand and scale rank in the top tier of their respective niche markets

Weaknesses

• VITAS revenue is overly reliant on a single payer, Medicare
• Roto-Rooter organic search traffic share dropped from nearly 60% to below 40%, structurally raising customer acquisition costs
• The two businesses lack synergies, often dragging down the overall valuation

Opportunities

• The ongoing US aging silver tsunami continues to expand hospice care demand
• Spinning off or dividing Roto-Rooter can unlock pure-play business valuation
• Acquiring and consolidating fragmented hospice peers

Threats

• Risks of Medicare reimbursement policy and payment cap adjustments
• Further search engine algorithm changes exacerbating marketing inflation
• Regulatory and fraud audit pressures faced by the hospice industry